Genflow Biosciences plc (GENF.L) LSE
2.13
+0.025(+1.19%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
2.13
+0.025(+1.19%)
Currency In GBp
Address
15 Ingestre Place
London, W1F 0DU
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 32 4774 95881
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
January 17, 2022
| Name | Title | Pay | Year Born |
| Eric Jean Leire | Founder, Chief Executive Officer & Executive Director | 246,405 | 1958 |
| Cedric Szpirer | Head of CMC | 0 | N/A |
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.